American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.
about
Comparison of the efficacy of saline, local anesthetics, and steroids in epidural and facet joint injections for the management of spinal pain: A systematic review of randomized controlled trialsPharmacotherapy for adverse events reduces the length of hospital stay in patients admitted to otolaryngology ward: a single arm intervention studyThe Basic Pharmacology of Opioids Informs the Opioid Discourse about Misuse and Abuse: A ReviewRisks, management, and monitoring of combination opioid, benzodiazepines, and/or alcohol use.The effect of EHR-integrated patient-reported outcomes on satisfaction with chronic pain careIndicators of drug-seeking aberrant behaviours: the feasibility of use in observational post-marketing cohort studies for risk managementToward a systematic approach to opioid rotation.Guideline for opioid therapy and chronic noncancer pain.Chronic opioid therapy urine drug testing in primary care: prevalence and predictors of aberrant resultsPharmacological and toxicological profile of opioid-treated, chronic low back pain patients entering a mindfulness intervention randomized controlled trial.Analysis of efficacy differences between caudal and lumbar interlaminar epidural injections in chronic lumbar axial discogenic pain: local anesthetic alone vs. local combined with steroids.The individual and societal burden of chronic pain in Europe: the case for strategic prioritisation and action to improve knowledge and availability of appropriate carePrescription practices involving opioid analgesics among Americans with Medicaid, 2010Self-reports of medication side effects and pain-related activity interference in patients with chronic pain: a longitudinal cohort study.Need and utility of a polyethylene glycol marker to ensure against urine falsification among heroin usersCorrelates of Opioid Use in Adults With Self-Reported Drug Use Recruited From Public Safety-Net Primary Care Clinics.SCOPE of Pain: An Evaluation of an Opioid Risk Evaluation and Mitigation Strategy Continuing Education Program.Probability and predictors of treatment-seeking for prescription opioid use disorders: a national study.Opioid Prescribing at Hospital Discharge Contributes to Chronic Opioid Use.Prescribed opioids in primary care: cross-sectional and longitudinal analyses of influence of patient and practice characteristicsTwenty-five years of prescription opioid use in Australia: a whole-of-population analysis using pharmaceutical claimsUse and nonmedical use of prescription opioid analgesics in the general population of Canada and correlations with dispensing levels in 2009.Update on prescription extended-release opioids and appropriate patient selection.Racial disparities across provider specialties in opioid prescriptions dispensed to medicaid beneficiaries with chronic noncancer painA Tool to Assess Risk of De Novo Opioid Abuse or Dependence.Clinical practice guidelines for the management of chronic musculoskeletal pain in primary healthcare: a systematic review.Guidelines for prescribing opioids for chronic non-cancer pain in Korea.Co-prescription of opioids with benzodiazepine and other co-medications among opioid users: differential in opioid dosesBenzodiazepine use in patients with chronic pain in an interdisciplinary pain rehabilitation program.Characteristics of chronic pain patients who take opioids and persistently report high pain intensity.Post-operative opioid pain management patterns for patients who receive hip surgery.Pressure sensitivity and phenotypic changes in patients with suspected opioid-induced hyperalgesia being withdrawn from full mu agonists.Patterns of care and side effects for patients prescribed methadone for treatment of chronic pain.Incidence and Predictors of Opioid Prescription at Discharge After Traumatic Injury.Past-year prevalence of prescription opioid misuse among those 11 to 30years of age in the United States: A systematic review and meta-analysis.Risk Factors for Serious Prescription Opioid-Induced Respiratory Depression or Overdose: Comparison of Commercially Insured and Veterans Health Affairs Populations.Validation of a Screening Risk Index for Serious Prescription Opioid-Induced Respiratory Depression or Overdose in a US Commercial Health Plan Claims Database.Controlled Substance Agreements for Opioids in a Primary Care Practice.Interviewing and Urine Drug Toxicology Screening in a Pediatric Pain Management Center: An Analysis of Analgesic Nonadherence and Aberrant Behaviors in Adolescents and Young Adults.The risks of opioid treatment: Perspectives of primary care practitioners and patients from safety-net clinics.
P2860
Q28394038-53E2A1E3-9D62-4686-8EC0-CD0CEAAB1764Q28542923-0C55E2CB-B3DA-4903-856F-2C783CB1CECDQ30235088-5A31116C-8BDA-40C8-968C-E8B96CA5A704Q33753044-E34DA66D-BF13-48D8-BE01-6FA06BF9F966Q33768858-5C806A34-2BFD-4192-8322-1CB4B3C81190Q34051869-541AEF73-4A20-40D5-90B7-07A0AF0DEAFCQ34394425-0D446F77-4149-4BB1-8E94-1C863F128EFBQ34556388-295EBA4E-E3C4-4E3A-9654-E19E9E86B1E0Q34566925-47F19759-3B2D-473D-A0A6-1A688B9B4668Q35064172-9E14E468-A93C-473F-A67C-22F8561BFDAEQ35069167-435B9B06-A9AB-429C-8361-1C4975194418Q35074737-D4D4C398-EAB2-418A-A7B4-8B69908F3CCFQ35194756-3CE82AD5-6E06-4D39-B322-3B8211447705Q35607067-CF010284-4A70-4940-8745-F801CB006014Q35875443-9E72A435-BE31-4239-8AEE-F1ED70D940F9Q36163633-E8A410C4-742D-4D44-8CAB-0A6CEA863DB3Q36478691-D1545152-F6ED-478F-9110-AABAEB976DF8Q36794523-5EE01B95-D491-4C6E-9BD5-A25DD139DAA4Q36808956-2C2527E5-C8E3-491D-BA36-2FF07439F8D3Q36920021-05949FE6-5925-4C86-BFDF-6E5B80AA23BDQ37030675-CB781247-DE59-4330-A15C-A8DD732E426DQ37031537-87E28F32-9BCA-4328-A343-36D00E22DECFQ37053718-4543B2B2-E9E1-47C5-9986-D153C2C3EEFEQ37235336-0D1CE299-C3C1-4394-BC05-E8FE26854172Q37361201-6D127916-EDBC-4FF8-A6E4-789B43413F27Q37566942-B9BFDAA0-56D6-48DF-B788-5D0552F5DC07Q37599814-F36A55C9-2948-4E6F-8B7C-26B8BEB3A1D9Q37613749-3183BCEF-4672-4304-93D8-4734B0AF7EAFQ37643464-15765AB0-D14A-4448-BAFC-703A99CBC3FAQ37650943-ECF2675A-2B86-4BFE-9DF2-CC1DDE29C9BCQ37705000-EE3BA517-E7B8-4FF4-9663-9742453EAD0CQ37725752-EA8D1A8B-8CA6-4C5C-8997-D2E611BA440CQ37727234-4220CCE6-01EA-4102-A013-22BF75A45607Q38715555-13D4E460-572B-4120-B9B8-F4759BD359C1Q38801739-C853254E-8BEA-42FD-B60F-F616B002E259Q38832250-B4B8B74B-548D-4C81-AC46-99B33CD8D03DQ38878642-45320A8D-0CCF-4CE4-95B2-9C14115BF04FQ41154468-074B5BE8-1809-44DA-87DE-1A2CA24E0F60Q41255699-8973ABF9-FC2C-4F16-9C76-C0448B6BF475Q41499781-E8D636D5-8744-4347-BA88-C47688B50F6F
P2860
American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
American Society of Interventi ...... cancer pain: Part 2--guidance.
@en
American Society of Interventional Pain Physicians
@nl
type
label
American Society of Interventi ...... cancer pain: Part 2--guidance.
@en
American Society of Interventional Pain Physicians
@nl
prefLabel
American Society of Interventi ...... cancer pain: Part 2--guidance.
@en
American Society of Interventional Pain Physicians
@nl
P2093
P1476
American Society of Interventi ...... -cancer pain: Part 2--guidance
@en
P2093
Aaron K Calodney
Adam M Kaye
Alan D Kaye
Allan T Parr
Allen W Burton
American Society of Interventional Pain Physicians
Bert Fellows
Bradley W Wargo
Brian M Bruel
Carl C Balog
P304
P433
P577
2012-07-01T00:00:00Z